awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37972767-07F9487C-3D29-44FF-83A5-0DDE6F91768D
Q37972767-07F9487C-3D29-44FF-83A5-0DDE6F91768D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37972767-07F9487C-3D29-44FF-83A5-0DDE6F91768D
Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
P2860
Q37972767-07F9487C-3D29-44FF-83A5-0DDE6F91768D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37972767-07F9487C-3D29-44FF-83A5-0DDE6F91768D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f991e4272fa6462d5f5c61081d5f9b3831bb729
P2860
The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors